| 摘要 |
A serum cholesterol lowing agent or a preventive or therapeutile agent for atherosclerosis, which each comprises a combination of a compound represented by the following general formula (I) or pharmaceutical acceptable salts thereof with a cholesterol biosynthesis inhibitor and/or a fibrate type cholesterol lowing agent. (I) (b) (a) [In the formula, A<SUB>1</SUB>, A<SUB>2</SUB>, A<SUB>3 </SUB>and A<SUB>4 </SUB>each is hydrogen, a group represented by the formula (b), or a group represented by the formula (a), provided that at least one of these is a group represented by the formula (a); A<SUB>2 </SUB>is C<SUB>1-5 </SUB>alkyl etc; and n. p, q and r each is an integer of 0, 1 or 2.
|
